Description

2,3,4,4A,5,6-Hexahydro-9-(Trifluoromethyl)-1H-Pyrazino(1,2-A)Quinoline is a sophisticated heterocyclic organic compound featuring a fused pyrazinoquinoline core structure substituted with a trifluoromethyl group. This molecular architecture makes it a valuable advanced pharmaceutical intermediate and a key building block for medicinal chemistry research. It is primarily utilized by R&D chemists and process development scientists in the pharmaceutical and agrochemical sectors for the synthesis of novel active ingredients.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of potential drug candidates, particularly those targeting central nervous system (CNS) disorders.
• Medicinal Chemistry Research: Used as a scaffold or building block for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Agrochemical Development: Acts as an intermediate in the research and development of new crop protection agents and pesticides.
• Chemical Synthesis: Employed in organic synthesis for the construction of complex nitrogen-containing heterocycles due to its unique fused ring system.
• Fluorinated Compound Synthesis: The presence of the trifluoromethyl group makes it a valuable starting material for introducing fluorine into target molecules to modulate their physicochemical properties.

Basic Information

Item	Details
Product Name	2,3,4,4A,5,6-Hexahydro-9-(Trifluoromethyl)-1H-Pyrazino(1,2-A)Quinoline
CAS No.	96430-25-0
Molecular Formula	C₁₄H₁₅F₃N₂
Molecular Weight	268.28 g/mol
Synonyms	9-(Trifluoromethyl)-1,2,3,4,4a,5,6,10b-octahydropyrazino[1,2-a]quinoline; 9-(Trifluoromethyl)-1H,2H,3H,4H,4aH,5H,6H-pyrazino[1,2-a]quinoline; Hexahydro-9-(trifluoromethyl)pyrazino[1,2-a]quinoline; 96430-25-0; Pyrazino[1,2-a]quinoline, 2,3,4,4a,5,6-hexahydro-9-(trifluoromethyl)-; 9-Trifluoromethyl-1,2,3,4,4a,5,6,10b-octahydro-pyrazino[1,2-a]quinoline
EINECS	Contact for details

Quality Control

Our 2,3,4,4A,5,6-Hexahydro-9-(Trifluoromethyl)-1H-Pyrazino(1,2-A)Quinoline is produced under a strict quality management system. Every batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specified parameters. Our quality commitment supports compliance with cGMP standards for pharmaceutical intermediate applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep away from incompatible materials such as strong alkalis and fluorides. For long-term storage, consider inert gas purging to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder or crystalline solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.